Pelicano H, Maury G, Elalaoui A, Shafiee M, Imbach J L, Goody R S, Divita G
Université de Montpellier II Sciences et Techniques du Languedoc, URA 488 du CNRS, France.
Eur J Biochem. 1997 Sep 15;248(3):930-7. doi: 10.1111/j.1432-1033.1997.00930.x.
Adenosine kinase (AK) catalyzes the phosphorylation of adenosine to AMP with ATP as phosphate donor. Intrinsic fluorescence of bovine liver AK was shown previously to be a sensitive probe to quantify the binding of substrates to the enzyme [Elaloui, A., Divita, G., Maury, G., Imbach, J.-L. & Goody, R. S. (1994) Eur. J Biochem. 221, 839-846]. AK contains two catalytic, sites: a high-affinity site, which binds adenosine and AMP selectively; and a site for ATP and ADP. In the present work, these two sites were characterized by combining the quenching of protein fluorescence induced by the binding of the ligands and the fluorescence enhancement observed upon binding of the N-methylanthraniloyl-derivated nucleotides or adenosine. A new fluorescent analog of adenosine, 5'-N-methylanthraniloyl-adenosine, was synthesized and shown to bind selectively to the high-affinity adenosine-binding site with an affinity similar to that of adenosine (Kd 1 microM). In contrast, 2'(3')-N-methylanthraniloyl derivatives of ATP, adenosine (5')tetraphospho(5')adenosine (Ap4A), and adenosine (5')pentaphospho(5')adenosine (Ap5A), bind to the enzyme at the ATP site. Methylantraniloyl derivatives of ATP and adenosine were used as tools for selective characterization of a series of adenosine analogues. The bisubstrate inhibitors Ap4A and Ap5A bind to the ATP site with high affinity and apparently not to the adenosine site, thus acting more as ATP analogues than true bisubstrate ligands. The binding properties of a series of adenosine analogues were strongly dependent on the structural modifications on adenosine. The analogues modified at positions 2' or 3' show similar affinities for AK as that of adenosine, whereas adenosine analogues modified at the base present a relatively low affinity for the enzyme.
腺苷激酶(AK)催化以ATP作为磷酸供体将腺苷磷酸化为AMP。先前已表明牛肝AK的内在荧光是一种灵敏的探针,可用于定量底物与该酶的结合[Elaloui, A., Divita, G., Maury, G., Imbach, J.-L. & Goody, R. S. (1994) Eur. J Biochem. 221, 839 - 846]。AK含有两个催化位点:一个高亲和力位点,它选择性地结合腺苷和AMP;以及一个结合ATP和ADP的位点。在本研究中,通过结合配体结合诱导的蛋白质荧光猝灭以及N - 甲基邻氨基苯甲酰基衍生的核苷酸或腺苷结合时观察到的荧光增强,对这两个位点进行了表征。合成了一种新的腺苷荧光类似物5'-N - 甲基邻氨基苯甲酰基 - 腺苷,并表明它以与腺苷相似的亲和力(Kd 1 microM)选择性地结合到高亲和力腺苷结合位点。相比之下,ATP、腺苷(5')四磷酸(5')腺苷(Ap4A)和腺苷(5')五磷酸(5')腺苷(Ap5A)的2'(3')-N - 甲基邻氨基苯甲酰基衍生物在ATP位点与该酶结合。ATP和腺苷的甲基邻氨基苯甲酰基衍生物被用作选择性表征一系列腺苷类似物的工具。双底物抑制剂Ap4A和Ap5A以高亲和力结合到ATP位点,显然不结合到腺苷位点,因此它们更像是ATP类似物而不是真正的双底物配体。一系列腺苷类似物的结合特性强烈依赖于腺苷上的结构修饰。在2'或3'位修饰的类似物对AK的亲和力与腺苷相似,而在碱基处修饰的腺苷类似物对该酶的亲和力相对较低。